Ionis Pharmaceuticals: Two FDA Approvals, Half the Stock Price
September 17, 2026
Vertex: A $10 Billion Bet Lands the Same Week a New Drug Crosses $1 Billion
September 22, 2026
Zoetis cut its full-year revenue forecast to $9.220 billion to $9.320 billion, representing organic operational decline of 2 percent to 1 p
Read moreDetailsSubscribe to our mailing list to receives daily updates direct to your inbox!
Joby Aviation lifted its full-year 2026 revenue guidance by 15 percent and completed the first crewed eVTOL flights under the...
In one breath Adaptive Biotechnologies spent six straight years burning more cash than it earned, losing more than a dollar...
For most of its public life, Vericel lost money while growing fast. It sells two unusual things: living skin grafts...
The Federal Reserve spent most of 2024 and 2025...
Three things that should not all be true at...
For most of the past two years, the Federal...
Revenue has fallen every year since 2020. The stock just...
The Federal Reserve spent most of 2024 and 2025 cutting...
© 2026 BullScope. Evidence-first investment research. Not investment advice. · Methodology · Privacy Policy · Terms of Use · Disclaimer
© 2026 BullScope. Evidence-first investment research. Not investment advice. · Methodology · Privacy Policy · Terms of Use · Disclaimer